Cargando…
Establishment and validation of a drug-target microarray for SARS-CoV-2
COVID-19 has become one of the worst epidemic in the world, currently already more than four million people have been infected, which probably co-exist with human beings, and has a significant impact on the global economy and political order. In the process of fighting against the epidemic in China,...
Autores principales: | Chen, Peng, Zeng, Zehua, Du, Hongwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373225/ https://www.ncbi.nlm.nih.gov/pubmed/32828312 http://dx.doi.org/10.1016/j.bbrc.2020.05.217 |
Ejemplares similares
-
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020) -
High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors
por: Zhao, Yao, et al.
Publicado: (2021) -
The SARS-CoV-2 main protease as drug target
por: Ullrich, Sven, et al.
Publicado: (2020) -
Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK
por: du Plessis, Louis, et al.
Publicado: (2021) -
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)